NKTX: Major data update on CAR NK cell therapy for autoimmune diseases expected in 2026
The conference highlighted progress in allogeneic CAR NK cell therapy for autoimmune diseases, with ongoing trials in lupus nephritis and other indications. Key updates include improved conditioning regimens, outpatient dosing, and a major data readout planned for 2026.Based on Nkarta, Inc. [NKTX…